Shuttle Pharmaceuticals Holdings, Inc. SHPH
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 15.50% | -3.39% | -28.18% | -16.53% | -68.75% |
| Total Depreciation and Amortization | 59,780.77% | 6,206.52% | 5,174.55% | -50.88% | -61.76% |
| Total Amortization of Deferred Charges | -84.02% | 9.31% | -94.26% | -96.89% | -84.92% |
| Total Other Non-Cash Items | 23.98% | -40.27% | 126.92% | -40.86% | 533.80% |
| Change in Net Operating Assets | 116.26% | -1,534.86% | 288.99% | -175.65% | 74.63% |
| Cash from Operations | 37.71% | -8.79% | -29.40% | -96.50% | -101.91% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -105.07% | -101.71% | -100.41% | -100.00% | 23.67% |
| Cash from Investing | -614.66% | -209.88% | -204.83% | -100.00% | 25.45% |
| Total Debt Issued | 380.77% | -- | -- | 216.00% | -- |
| Total Debt Repaid | 87.67% | 86.70% | 79.02% | 78.84% | 36.65% |
| Issuance of Common Stock | -57.30% | -1.88% | 194.84% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 95.63% | 57.87% | -69.98% | -790.95% | -- |
| Cash from Financing | -20.36% | 1.43% | 191.65% | 1,371.84% | 1,659.19% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -214.68% | -209.91% | -141.69% | 151.97% | 186.76% |